Randomized, double-blind, placebo-controlled trial of MUC1 vaccine in patients with newly diagnosed advanced adenoma
Ended Awarded Last action
- Contract number
- HHSN26100011
- Awardee
-
Mayo Clinic UEI Y2K4F9RPRRG7
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $89,746
Award facts
- Opportunity
-
- N01CN0501469 Solicitation number
- Contract value 100% obligated
- $89,746.31 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost No Fee
- Place of performance
- Rochester, MN 55905, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$11,140 | |
| Change Order | $0 | |
| Change Order | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $24,580 | |
| Original award | $76,306 |
About this award
This federal contract award is to Mayo Clinic, a large non-profit academic medical center, for a randomized, double-blind, placebo-controlled clinical trial of a MUC1 vaccine in patients with newly diagnosed advanced adenoma. The contract was awarded by the National Cancer Institute, part of the National Institutes of Health, and is funded under the Cancer Prevention Agent Development Program for early-phase clinical research. The contract has a total ceiling value of $89,746.31 and was awarded on August 8, 2016, with a final completion date of September 22, 2021. This contract is not set-aside and is a delivery order under a cost-no-fee pricing type. Mayo Clinic is a well-established federal contractor and grantee, providing a wide range of biomedical research, healthcare, and education services to various federal agencies.
Quick answers
Who was awarded contract HHSN26100011?
HHSN26100011 was awarded to Mayo Clinic by National Cancer Institute (National Institutes of Health) on August 8, 2016.
How much is contract HHSN26100011 worth?
The government has obligated $89,746 on HHSN26100011.
Is contract HHSN26100011 an order under another contract?
Yes. HHSN26100011 is a delivery order under HHSN261201200042I, an indefinite delivery contract.
Was contract HHSN26100011 competed?
The extent of competition for HHSN26100011 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award